Antineoplaston A10
N/A
Report date: 2022/08/29 20:00:24
NME
Base Information
Drug NameAntineoplaston A10
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBurzynski Research Institute (Bri)
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBurzynski Research Institute (Bri)
Active IndicationsN/A
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A